1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MEK
  4. MEK Inhibitors

MEK Inhibitors

MEK1

MEK2

MEK5

MEK

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

MEK Inhibitors, Antagonists & Activators
Product Name MEK1 MEK2 MEK5 MEK Purity
Trametinib
MEK1, IC50: 2 nM
MEK2, IC50: 2 nM
    99.96%
Mirdametinib
MEK1, Ki: 1 nM
MEK2, Ki: 1 nM
 
MEK, IC50: 0.33 nM
99.95%
PD98059
MEK1, IC50: 2-7 μM
MEK2, IC50: 50 μM
    99.96%
U0126-EtOH
MEK1, IC50: 70 nM
MEK2, IC50: 60 nM
    99.41%
Selumetinib
MEK1, IC50: 14 nM
   
MEK, IC50: 12 nM
99.87%
TERT activator-1
MEK1
MEK2
    99.50%
U0126
MEK1, IC50: 70 nM
MEK2, IC50: 60 nM
    98.45%
Cobimetinib
MEK1, IC50: 4.2 nM
      99.73%
Binimetinib      
MEK, IC50: 12 nM
99.52%
C16-PAF      
MEK
99.85%
Isorhamnetin
MEK1
      99.94%
Avutometinib      
MEK, IC50: 160 nM
99.02%
Trametinib (DMSO solvate)
MEK1, IC50: 2 nM
MEK2, IC50: 2 nM
    99.56%
Lidocaine      
MEK
99.96%
trans-Zeatin      
MEK
99.83%
CI-1040
MEK1, IC50: 17 nM
      99.90%
Pimasertib
MEK1
MEK2
    99.88%
GDC-0623
MEK1, Ki: 0.13 nM (+ATP)
      99.15%
Lidocaine hydrochloride      
MEK
99.96%
BIX02189    
MEK5, IC50: 1.5 nM
  99.99%
Refametinib
MEK1, IC50: 19 nM
MEK2, IC50: 47 nM
    99.82%
Lixisenatide
MEK1
MEK2
    99.93%
Trametiglue
MEK1
MEK2
    98.58%
TAK-733      
MEK, IC50: 3.2 nM
98.31%
AZD8330
MEK1, IC50: 7 nM
MEK2, IC50: 7 nM
    99.14%
MS432
MEK1, DC50: 31 nM (in HT29 cells)
MEK1, DC50: 31 nM (in SK-MEL-28 cells)
MEK2, DC50: 17 nM (in HT29 cells)
MEK2, DC50: 9.3 nM (in SK-MEL-28 cells)
    99.78%
APS-2-79
MEK1
      99.38%
BI-847325  
MEK2, IC50: 4 nM
    98.15%
SL327
MEK1, IC50: 180 nM
MEK2, IC50: 220 nM
    ≥98.0%
RGB-286638
MEK1, IC50: 54 nM
      99.70%
RO4987655
MEK1, IC50: 5.2 nM
MEK2, IC50: 5.2 nM
    99.26%
Azelnidipine
MEK1
MEK2
    99.66%
MAP855
MEK1, IC50: 3 nM
      99.38%
Lidocaine (Standard)      
MEK
99.85%
Tunlametinib
MEK1
MEK2
    98.25%
GW284543    
MEK5
  99.99%
Zapnometinib      
MEK, IC50: 5.7 nM
99.85%
BIX02188    
MEK5, IC50: 4.3 nM
  99.85%
Cobimetinib hemifumarate
MEK1, IC50: 4.2 nM
      99.73%
PD318088
MEK1
MEK2
    99.91%
RGB-286638 free base
MEK1, IC50: 54 nM
      98.07%
MEK inhibitor      
MEK
98.35%
PD184161      
MEK, IC50: 10-100 nM
98.08%
Lidocaine hydrochloride hydrate      
MEK
99.90%
Hypothemycin
MEK1, Ki: 17 nM
MEK2, Ki: 38 nM
    ≥98.0%
PD 198306      
MEK
99.75%
PD0325901-O-C2-dioxolane
MEK1
MEK2
    98.76%
E6201
MEK1, IC50: 5.2 nM
     
Refametinib (R enantiomer)      
MEK, EC50: 2-15 nM
PD-334581
MEK1
      99.72%
MEK-IN-6      
MEK
98.69%
APS-2-79 hydrochloride
MEK1
     
Balamapimod      
MEK
GW284543 hydrochloride    
MEK5
 
MEK/RAF-IN-1
MEK1, IC50: 28 nM
     
MEK/PI3K-IN-2
MEK1, IC50: 352 ± 2 nM
     
MEK/PI3K-IN-1
MEK1, IC50: 124 ± 11 nM
     
Isorhamnetin (Standard)
MEK1
     
CHMFL-EGFR-202
MEK1, IC50: 161 nM
      99.75%
MEK-IN-6 hydrate      
MEK
MEK-IN-1      
MEK